Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-13-054687)

Filing Details

Accession Number:: 0001209191-13-054687
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-12-02 16:25:00
Reporting Period:: 2013-07-22

Filing Date:: 2013-12-02
Accepted Time:: 2013-12-02 16:25:00
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1389545	Novabay Pharmaceuticals Inc.	NBY	Pharmaceutical Preparations (2834)	680454536

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1593299	Ltd Holdings Pharma Pioneer China	190 Elgin Avenue, George Town, Grand Cayman E9 KY1-9005		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-07-22	3,913	$0.00	2,005,656	No	4	J	Indirect	By Pioneer Pharma (Singapore) Pte. Ltd.
Common Stock	Acquisiton	2013-11-14	108,156	$1.02	108,156	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	J	Indirect	By Pioneer Pharma (Singapore) Pte. Ltd.
No	4	P	Direct

Footnotes

The shares were issued pursuant to an International Distribution Agreement dated as of September 13, 2012, between the Issuer and an affiliate of Pioneer Pharma (Singapore) Pte. Ltd.
The shares are held by Pioneer Pharma (Singapore) Pte. Ltd., which is a wholly owned subsidiary of Pioneer Pharma (Hong Kong) Company Limited, which is a wholly owned subsidiary of the Reporting Person.